Digital Healthcare award for CENTOGENE

By Helen Adams
Biotechnology company CENTOGENE has won the Health-i award in digital healthcare innovation for its artificial intelligence platform

Centogene a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, today announced that it has been awarded the Health-i Award, which recognizes companies that are transforming healthcare in Germany and beyond.

Founded in 2006 and headquartered in Rostock, Germany, Centogene diagnoses rare diseases, using its knowledge and expanding collection of data.


AI-powered biomarker platform

The Health-i Award winners are chosen by industry and research experts, across groups which are advancing healthcare innovation. 

Centogene won for its AI-powered biomarker platform, CentoMetabolome. 

Biomarkers enable healthcare professionals to identify the details of a disease.

The CentoMetabolome platform can transform the way biomarkers are detected - meaning research, diagnosis and treatment can be conducted much faster, leading to recovery.

Germany’s Health-i Awards are sponsored by:

  • Germany’s biggest public health insurance provider Techniker Krankenkasse
  • German newspaper Handelsblatt


Artificial intelligence supports digital health innovations

This AI development is another proud step forward for CENTOGENE’s mission to cure more diseases.

“We are proud to be recognised for our impact in the healthcare industry and the innovation we are bringing with our unique leading metabolomics platform”, said Carsten Ullrich, Senior Director of Artificial Intelligence. “Working together across several departments, we have been able to fully leverage CENTOGENE’s expertise in omics, extensive global insights from our rare disease-centric Bio/Databank, and advanced AI tools. 

“As a result, we can now analyse the dynamics of diseases to drive biomarker discovery and test drug candidates as we continue our mission to enable the cure of 100 rare diseases in 10 years.” 



Featured Articles

Cancer Vaccines Breakthrough a Glimpse of Healthcare Future

As the UK's NHS becomes the first healthcare provider to launch a cancer vaccine testing programme, we explore this groundbreaking oncological treatment

Change Healthcare Cyberattack Fallout Continues

Three months on, the cyberattack on UnitedHealth Group's Change Healthcare is still affecting US citizens, with delays and

McKinsey: National E-health Initiatives on the Rise

McKinsey report on countries that are scaling national e-health programmes says it is easing financial pressures on healthcare systems globally

Edwards Lifesciences: a Profile of the Heart Tech Specialist

Medical Devices & Pharma

London Hospitals Cyberattack Wreaks Healthcare Havoc

Technology & AI

Healthcare Provision in India: Challenges and Opportunities

Health Insurance & Finance